Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Federal health officials won’t put new restrictions on the use of a mercury-based preservative in vaccines and other medicines. A group called the Coalition for Mercury-free Drugs petitioned the Food and Drug Administration in 2004 seeking the restrictions on thimerosal, citing concerns that the preservative is linked to autism. The FDA rejected the petition. Thimerosal, about 50 percent mercury by weight, has been used since the 1930s to kill microbes in vaccines. There have been suspicions that thimerosal causes autism. However, studies that tracked thousands of children consistently have found no association between the brain disorder and the mercury-based preservative. Critics contend the studies are flawed. Since 2001, all vaccines given to children 6 and younger have been either thimerosal-free or contained only trace amounts of the preservative. Thimerosal has been phased out of some, but not all, adult vaccines as well. Most doses of the flu vaccine still contain thimerosal. There also are minute amounts of mercury, as thimerosal or phenylmercuric acetate, in roughly 45 eye ointments, nasal sprays and nasal solutions, the FDA said.

Note: Why are they still using mercury in flu shots when it is not necessary? Heavy metals are well known to be toxic to the human body. The studies mentioned above are almost entirely funded by pharmaceutical interests and government bodies working with them. For lots more on this major cover-up, click here.

Federal health officials have decided to forgo gathering detailed data on whether children in 22 big cities are receiving recommended immunizations and instead will survey teenagers, who are the target of several new vaccines. The decision is drawing protests from local health officials, who say the soon-to-be-lost information is essential to their efforts to make sure that infants and toddlers, many from poor families, are protected against childhood infections. Each year, the CDC contracts a polling company to get data on vaccination rates in various age, demographic and income groups nationwide. "We need to know if the new vaccine has helped, or had no change, or hurt [coverage], and we cannot really make those judgments without the NIS data," [one health official] said. CDC officials said they are redirecting about $3 million to survey adolescents. The only way to pay for the 22-city sampling would be to use money now used to help states buy vaccine, they added. The decision comes at a time when the government is spending record amounts on public health. The CDC's budget has risen 42 percent since 2001 and is now $8.73 billion.

Note: This unusual decision makes sense if you consider that the powerful pharmaceutical industry doesn't want tracking on toddler vaccinations, as it may show what they have long denied -- that there is a link between autism and childhood vaccinations. The mercury-derivative Thimerosal was largely taken out of childhood vaccinations just a few years ago. The much-awaited data needed to prove or disprove a link will now be more difficult to obtain.

Hoping to prevent Congress from letting the government negotiate lower drug prices for millions of older Americans on Medicare, the pharmaceutical companies have been recruiting Democratic lobbyists [and] lining up allies in the Bush administration and Congress. Many drug company lobbyists concede that the House is likely to pass a bill intended to drive down drug prices, but they are determined to block such legislation in the Senate. If that strategy fails, they are counting on President Bush to veto any bill that passes. With 49 Republicans in the Senate next year, the industry is confident that it can round up the 34 votes normally needed to uphold a veto. They began developing strategy last week at a meeting of the board of the Pharmaceutical Research and Manufacturers of America. Billy Tauzin, president of that group [and] a former congressman...met with Senator Byron L. Dorgan, a North Dakota Democrat who has been trying for six years to allow drug imports from Canada. The industry vehemently opposes such legislation. The 2003 Medicare law prohibits the federal government from negotiating drug prices or establishing a list of preferred drugs. Drug makers have not set a budget for their campaign. They and their trade groups already spend some $100 million a year on lobbying in Washington. Representative Frank Pallone Jr., Democrat of New Jersey [said] “The 2003 Medicare law was essentially written by the drug industry.” Drug companies may be open to some changes in the Medicare drug benefit, but they say they cannot accept any form of price negotiation.

Note: For lots of verifiable information on the power of the drug industry to corrupt Congress, click here.

The Department of Agriculture declared safe for human consumption yesterday an experimental variety of genetically engineered rice found to have contaminated the U.S. rice supply this summer. The move ... to deregulate the special long-grain rice, LL601, was seen as a legal boon to its creator, Bayer CropScience. The company applied for approval shortly after the widespread contamination was disclosed in August and now faces a class-action lawsuit filed by hundreds of farmers in Arkansas and Missouri. The experimental rice ... escaped from Bayer's test plots after the company dropped the project in 2001. The resulting contamination, once it became public, prompted countries around the world to block rice imports from the United States, sending rice futures plummeting and farmers into fits. In approving the rice, the USDA allowed Bayer to take a regulatory shortcut and skip many of the usual safety tests. Joseph Mendelson, legal director of the nonprofit Center for Food Safety, said the quick approval shows that the USDA is more concerned about the fortunes of the biotechnology industry than about consumers' health. "USDA is telling agricultural biotechnology companies that it doesn't matter if you're negligent, if you break the rules, if you contaminate the food supply with untested genetically engineered crops, we'll bail you out," Mendelson said in a statement. Officials in Europe, where genetically altered rice is derisively dubbed "Frankenfood," made clear as recently as last week that European countries will not accept any U.S. rice, he said.

Note: For reliable information on the deception and dangers of GM (Genetically Modified) food, click here.

Note: We usually limit ourselves to information from sources known and respected by the public. For this message, we're making an exception. Jeff Rense of rense.com is a radio personality and researcher of major cover-ups with no strong credentials other than a large following of people convinced of the quality of his work. His popular website receives millions of visits a month. Below is vital information everyone should know.

Royal Raymond Rife was a brilliant scientist born in 1888 and died in 1971. He received 14 major awards and honors and was given an honorary Doctorate by the University of Heidelberg for his work. By 1933, he had ... constructed the incredibly complex Universal Microscope, which ... was capable of magnifying objects 30,000 times their normal size. With this incredible microscope, Rife became the first human being to actually see a live virus. In 1934, the University of Southern California appointed a Special Medical Research Committee to bring terminal cancer patients ... to Rife's San Diego Laboratory and clinic for treatment. The team included doctors and pathologists assigned to examine the patients - if still alive - in 90 days. After the 90 days of treatment, the Committee concluded that 86.5% of the patients had been completely cured. On November 20, 1931, forty-four of the nation's most respected medical authorities honored Royal Rife with a banquet. But by 1939, almost all of these distinguished doctors and scientists were denying that they had ever met Rife. The last thing in the world that the pharmaceutical industry wanted was ... a painless therapy that cured ... terminal cancer patients and cost nothing to use but a little electricity. It might give people the idea that they didn't need drugs. Medical journals, supported almost entirely by drug company revenues and controlled by the AMA, refused to publish any paper by anyone on Rife's therapy. Rife technology became public knowledge again in 1986 with the publication of The Cancer Cure That Worked, by Barry Lynes, and other material about Royal Rife and his monumental work.

Note: For excellent video documentaries, including interviews with Royal Rife: http://www.rifevideos.com. For an excellent website focused on Rife's work, click here. For more reliable, verifiable information on health cover-ups, click here.

President Bush issued an executive order Thursday allowing federal contractors rebuilding in the aftermath of Hurricane Katrina to pay below the prevailing wage. In a notice to Congress, Bush said the hurricane had caused "a national emergency" that permits him to take such action. Bush's action came as the federal government moved to provide billions of dollars in aid. The administration is using the devastation of Hurricane Katrina to cut the wages of people desperately trying to rebuild their lives and their communities.

When the Federal Emergency Management Agency's paperwork slowed the evacuation of patients from the airport, Acadian's frustrated medics waited with empty helicopters. "At one point I had 10 helicopters on the ground waiting to go," said Marc Creswell, an Acadian medic, "but FEMA kept stonewalling us with paperwork. Meanwhile, every 30 or 40 minutes someone was dying." The company sent in outside doctors and nurses. FEMA rejected the help because the doctors and nurses weren't certified members of a National Disaster Medical Team. "When the doctors asked why they couldn't help these critically ill people lying there unattended," Mr. Creswell recalled, "the FEMA people kept saying, 'You're not federalized.' "

The Aids epidemic may have been triggered by the mass vaccination campaign which eradicated smallpox. The World Health Organization, which masterminded the 13-year campaign, is studying new scientific evidence suggesting that immunization with the smallpox vaccine Vaccinia awakened the unsuspected, dormant human immuno defence virus infection (HIV). Doctors who accept the connection between the anti-smallpox campaign and the Aids epidemic now see answers to questions which had baffled them. How, for instance, the Aids organism, previously regarded by scientists as 'weak, slow and vulnerable,' began to behave like a type capable of creating a plague. The smallpox vaccine theory would account for the position of each of the seven Central African states which top the league table of most-affected countries; why Brazil became the most afflicted Latin American country; and how Haiti became the route for the spread of Aids to the US. The greatest spread of HIV infection coincides with the most intense immunization programmes. Although detailed figures of Aids cases in Africa are difficult to collect, the more than two million carriers, and 50,000 deaths...are concentrated in the Countries where the smallpox immunization programme was most intensive. Brazil, the only South American country covered in the eradication campaign, has the highest incidence of Aids in that region.

In June 2000, a group of top government scientists and health officials gathered for a meeting at the isolated Simpsonwood conference center ... to ensure complete secrecy. The federal officials and industry representatives had assembled to discuss a disturbing new study that raised alarming questions about the safety of a host of common childhood vaccines administered to infants and young children. A mercury-based preservative in the vaccines -- thimerosal -- appeared to be responsible for a dramatic increase in autism. But instead of taking immediate steps to alert the public and rid the vaccine supply of thimerosal, the officials and executives at Simpsonwood spent most of the next two days discussing how to cover up the damaging data. According to transcripts obtained under the Freedom of Information Act, many at the meeting were concerned about how the damaging revelations about thimerosal would affect the vaccine industry's bottom line. The CDC paid the Institute of Medicine to conduct a new study to whitewash the risks of thimerosal, ordering researchers to "rule out" the chemical's link to autism. Senate Majority Leader Bill Frist, who has received $873,000 in contributions from the pharmaceutical industry, has been working to immunize vaccine makers from liability in 4,200 lawsuits that have been filed by the parents of injured children. More than 500,000 kids currently suffer from autism. The disease was unknown until 1943, when it was identified and diagnosed among 11 children born in the months after thimerosal was first added to baby vaccines in 1931. Internal documents reveal that Eli Lilly, which first developed thimerosal, knew from the start that its product could cause damage -- and even death -- in both animals and humans.

Note: A good, though somewhat watered down version of the above article was published in the Boston Globe on July 1, 2005. To see this article on the Globe website, click here. For an excellent report endorsed by dozens of respected doctors and nurses on the serious risks and dangers of vaccines, click here. Watch an excellent video of Emmy award winning reporter Sharyl Attkisson exposing how the government fired an vaccine expert who found links to autism.

The afternoon after Kelly Kerns' 2-month-old daughter Kaylee got several vaccines was "living hell," with the child screaming and arching her back, her mother said. 'I kept telling myself everybody gets vaccinated – this is OK,' she said. When Kaylee was 18 months old, her white-blonde hair began falling out and she stopped talking. Meanwhile, Kerns had twin boys – Andrew and Daniel. When they were 15 months old, they received three vaccines. A week later, they stopped talking. All three children have since been diagnosed as autistic. Flu vaccine sold in multidose vials still contains the preservative, and the government urges flu shots for pregnant women and young children even though not enough thimerosal-free ones are available, critics say. Finding answers is tough because autism, a little-understood developmental disorder, often is diagnosed at the very ages when children get vaccines. The stories are remarkably similar: A seemingly normal child gets a shot and days, weeks or months later, withdraws from the world, stops speaking, becomes upset at random stimulation such as a doorbell, and adopts compulsive behaviors like head-banging.

Note: MSNBC appears to have removed this article, though you can still find it on this webpage. Thimerosal has now been removed from childhood vaccines, however the government and drug industry continue to deny that there is any link between mercury in vaccines and autism. And mercury is still commonly used in flu and other vaccines in the U.S. A document hidden by drug companies for two years all but proves that a commonly used vaccine is responsible for the deaths of countless toddlers within 10 days of receiving the vaccine. This document is discussed on the US National Institutes of Health website at this link. An article going into depth on this vital information is available here.

Government nutrition researcher [Dr. Mark Levine] has published new evidence that suggests vitamin C can work like chemotherapy - only better. But so far, he hasn't been able to interest cancer experts in conducting the kind of conclusive studies that, one way or the other, would advance treatment. "If vitamin C is useful in cancer treatment, that's wonderful. If it's not, or if it's harmful, that's fine, too," said Levine, a Harvard-educated physician at the National Institute of Diabetes and Digestive and Kidney Diseases. The distinction between oral and intravenous is crucial. The body automatically gets rid of extra C through urine. Levine's lab has shown that, at high concentrations, the vitamin is toxic to many types of cancer cells in lab dishes. But to get that much C into the body before it's eliminated, it must be put directly into the blood. Five out of nine types of cancer cells that were put in simulated body-cavity fluid died when concentrated ascorbate or peroxide was added to the dish. And the best part: This same lethal marinade had no effect on healthy cells. "Interest is definitely growing," said Kenneth Bock, physician and president of the American College for Advancement in Medicine, an alternative-medicine society that teaches ascorbate infusion protocols. The American Cancer Society and the American Association of Clinical Oncologists warn patients against high-dose C, as do leading cancer centers such as the University of Pennsylvania's and Memorial Sloan-Kettering.

Note: If the above link does not work, the article is also available on the website of the San Diego Union-Tribune. For why this is not making major headlines in the news, click here and here.

Poor people are needlessly dying because drug companies and the governments of rich countries are blocking the developing world from obtaining affordable medicines. Five years to the day after the Doha declaration - a groundbreaking deal to give poor countries access to cheap drugs - was signed at the World Trade Organisation, Oxfam says things are worse. The charity accuses the US, which champions the interests of its giant pharmaceutical companies, of bullying developing countries into not using the measures in the Doha declaration and the EU of standing by and doing nothing. Doha technically allows poor countries to buy cheap copies of desperately needed drugs, but the US is accused of trying to prevent countries such as Thailand and India, which have manufacturing capacity, [from] making and selling cheap generic versions so as to preserve the monopolies of the drug giants. "Rich countries have broken the spirit of the Doha declaration," said Celine Charveriat, head of Oxfam's Make Trade Fair campaign. "The declaration said the right things but needed political action to work and that hasn't happened. In fact, we've actually gone backwards. Many people are dying or suffering needlessly." The US has pursued its own free trade agreements with developing countries, tying them into much tighter observance of patent rights than anticipated at Doha. "The USA has also pressured countries for greater patent protection through threats of trade sanctions," the report says.

The Bush administration said on Sunday that it would strenuously oppose one of the Democrats’ top priorities for the new Congress: legislation authorizing the government to negotiate with drug companies to secure lower drug prices for Medicare beneficiaries. In an interview, Michael O. Leavitt, the secretary of health and human services, said he saw no prospect of compromise on the issue. Dozens of plans are available in every state. They charge different premiums and co-payments and cover different drugs. The 2003 Medicare law explicitly prohibits the federal government from negotiating drug prices or establishing a list of preferred drugs. Representative Nancy Pelosi, the California Democrat who is in line to become the House speaker, has said the House will take up legislation to repeal that ban in its first 100 hours under Democratic control. Senate Democrats have expressed a similar desire. The eight Democrats newly elected to the Senate all say Medicare should have the power to negotiate with drug makers.

Note: To understand how the drug companies have become the most powerful lobby in government and will compromise our health for their profits, read what a top MD has to say by clicking here.

After an avalanche of panicked inquiries from patients across the country who claim to have been stricken with a mysterious skin disease, the federal Centers for Disease Control and Prevention is preparing to begin a full investigation. The patients ... describe symptoms that include sores that are slow to heal, a sensation of things crawling through their skin, joint pain and persistent fatigue. Many say they believe they have Morgellons disease, a diagnosis that has received wide attention on the Internet but is viewed skeptically by some doctors. Morgellons disease joins a growing list of symptom clusters that public health officials have been forced to examine closely in part because of the organizing power and unprecedented reach of the Internet. Morgellons was brought to public attention by ... Mary Leitao, who in 2001 created a Web site describing the mysterious sores and bizarre threadlike extrusions that afflicted her young son. She said she had tried for years to find a medical explanation for his illness. Ultimately, she said, doctors accused her of staging it. After creating the Web site...she was inundated with e-mail messages from people who said they also had the disease. Many of the people who visit her site have been told by doctors that their symptoms are delusional. Several mothers...told her that they had lost custody of their children after doctors decided the youngsters’ symptoms were contrived. Doctors themselves are divided over whether Morgellons is a medical or a psychiatric illness. The patients are clearly suffering from something; it is just not clear what that something is. “I think it’s a real disease,” said Dr. Rafael Stricker, a physician in San Francisco who sees many patients claiming to have Morgellons. Many patients also test positive for Lyme disease.

Several government doctors say drug maker Eli Lilly & Co. subtly orchestrated medical guidelines for treatment of an often lethal blood infection, hoping to boost sales of a drug whose value is being debated. “This company is trying to insinuate its drug into many aspects of patient care that industry really shouldn’t be involved in,” said Dr. Naomi O’Grady, a critical care specialist at the National Institutes of Health. Three of her NIH colleagues claim in Thursday’s New England Journal of Medicine that Lilly worked through medical societies to influence standards for treating the blood infection, sepsis. Ultimately, Xigris was incorporated into the guidelines. Both the guidelines committee and a larger information campaign on sepsis were heavily funded by [Lilly]. Dr. Phil Dellinger, who helped lead the guidelines committee, said...“We’ve been catching grief because we’ve been taking a lot of Lilly money — and we’re appreciative of Lilly giving it.” The U.S. Food and Drug Administration approved Xigris in 2001, despite an evenly split vote by its advisory committee. The lead author of Thursday’s journal article, Dr. Peter Q. Eichacker, voted against approval. Some critics are unhappy that the drug, which works only for the sickest patients, was approved on the basis of a single experiment. Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. O’Grady, of NIH, said a panel of disease experts that she headed refused to endorse the sepsis guidelines largely because Lilly “convened the whole panel.”

Note: For lots more on how the powerful pharmaceutical industry endangers our lives, click here.

Three years after the Food and Drug Administration first hinted that it might permit the sale of milk and meat from cloned animals...the agency is poised to endorse marketing of the mass-produced animals for public consumption. The decision...is based largely on new data indicating that milk and meat from cloned livestock and their offspring pose no unique risks to consumers. On Thursday, advocacy groups filed a petition asking the FDA to regulate cloned farm animals one type at a time, much as it regulates new drugs, a change that would drastically slow marketing approval. "The available science shows that cloning presents serious food safety risks, animal welfare concerns and unresolved ethical issues that require strict oversight," the petition states. "The government talks about being science-based, and that's great, but I think there is another pillar here: the question of whether we really want to do this," said Carol Tucker Foreman, director of food policy at the Consumer Federation of America. Each clone is a genetic replica of the animal that donated the cell from which it was grown. It was October 2003 when the FDA released its first draft document concluding that clones and their offspring are safe to eat. But an agency advisory panel and the National Academies, while generally supportive, raised flags, citing a paucity of safety data. Clonal meat or milk would be impossible to authenticate, since there is no way to distinguish them from conventional products. "That you can go online today to any number of different Web sites and purchase semen from cloned bulls tells you there are cloned sires out there fathering calves in the food supply."

Note: For an ABC article on this, click here. If you believe that government agencies are unbiased on matters of public health, I most highly urge you to read our summary at http://www.WantToKnow.info/deception10pg

Witold Bialokur...can run 10 kilometers, or 6.2 miles, in less than 44 minutes. While Mr. Bialokur’s performance would be the envy of most young men, he is not young. Mr. Bialokur is 71. It is one of the persistent mysteries of aging, researchers say. Why would one person, like Mr. Bialokur, remain so hale and hearty while another, who had seemed just as healthy, start to weaken and slow down? Rigorous studies are now showing that seeing, or hearing, gloomy nostrums about what it is like to be old can make people walk more slowly, hear and remember less well, and even affect their cardiovascular systems. Positive images of aging have the opposite effects. The constant message that old people are expected to be slow and weak and forgetful is not a reason for the full-blown frailty syndrome. But it may help push people along that path.

Schizophrenia patients do as well, or perhaps even better, on older psychiatric drugs compared with newer and far costlier medications, according to a study published yesterday that overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year. The results are causing consternation. The researchers who conducted the trial were so certain they would find exactly the opposite that they went back to make sure the research data had not been recorded backward. The study was requested by Britain's National Health Service to determine whether the newer drugs -- which can cost 10 times as much as the older ones -- are worth the difference in price. While the researchers had expected a difference of five points on a quality-of-life scale -- showing the newer drugs were better -- the study found that patients' quality of life was slightly better when they took the older drugs. There has been a surge in prescriptions of the newer antipsychotic drugs in recent years, including among children. In an editorial accompanying the British study, the lead researcher in the U.S. trial asked how an entire medical field could have been misled into thinking that the expensive drugs, such as Zyprexa, Risperdal and Seroquel, were much better.

Note: Those who have read our two-page health cover-up summary know very well how the entire medical field could have been misled. For those who haven't seen it: http://www.WantToKnow.info/healthcoverup

Top officials at the Centers for Disease Control and Prevention received premium bonuses in recent years at the expense of scientists and others who perform much of the agency's scientific work. Those inside the office of the centers' director, Dr. Julie L. Gerberding, have benefited the most. From 2002 through mid-2006, William H. Gimson III, the agency's chief operating officer, received bonuses totaling $147,863. Before Dr. Gerberding's appointment, members of the C.D.C. director's inner circle rarely received premium bonuses. Because bonus money is limited...the growing share of premium bonuses for Dr. Gerberding's closest advisers has meant less money is available for some scientists and other workers. In addition to those within Dr. Gerberding's inner circle, the increase in large cash awards within the centers has mostly benefited employees in the agency's financial, computer and human resources departments -- not its scientists. Soon after arriving at the centers, Dr. Gerberding began a comprehensive reorganization of the agency. In its wake, many of the agency's senior scientists and leaders either left or have announced that they are planning to leave. The Washington Post and The Atlanta Journal-Constitution have reported on the turmoil at the centers in articles quoting disgruntled former senior scientists who said the changes had undermined the agency.

Note: Could it be that these bonuses are meant to keep top officials in line the the CDC's strong bias towards to pharmaceutical companies? For more vital information on this: http://www.WantToKnow.info/healthcoverup.

Most of the federal scientists who improperly accepted personal money from drug or biotechnology companies walked away with reprimands or were allowed to retire unscathed. Only two of the 44 scientists found to have violated rules governing private consulting deals are being investigated for possible criminal activity, and they remain on the government payroll. NIH spokesman John Burklow said his agency wanted eight others reviewed for possible crimes, but those cases were rejected by the investigating office at the U.S. Health and Human Services Department. The two still outstanding...both committed "serious misconduct," so grave that they would be fired if they were civilians, NIH internal ethics reports contend. [A Congressional] subcommittee is expected to question NIH officials about documents showing it approved several taxpayer-paid trips for [Dr. Trey] Sunderland to attend conferences and events in places like Hawaii and Toronto, even after recommending his firing. Of the 44 alleged offenders...the majority received reprimands or warnings for failing to properly obtain approvals for their outside consulting work. NIH ethics reports allege...two scientists had unauthorized, unreported deals with drug companies -- Sunderland earning more than $600,000 over eight years for consulting and speeches and [Dr. Thomas] Walsh more than $100,000 in five years -- and that their consulting improperly overlapped with government duties.

Note: The Los Angeles Times later reported that Dr. Sunderland was the first NIH scientist in 14 years to be found guily of conflict of interest laws. For more vital information on major collusion between government and the pharmaceutical companies: http://www.WantToKnow.info/healthcoverup.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.